TSE:TTI Stock Latest News
Company AnnouncementsThiogenesis Wins FDA IND Clearance for Once-Daily Cystinosis Drug TTI-01023d ago
Company AnnouncementsThiogenesis Advances TTI-0102 Pipeline as Shareholders Back Governance and Funding Moves1M ago
Company AnnouncementsThiogenesis Hires Brisco Capital and Moves to Expand Equity Incentive Plan1M ago
Company AnnouncementsThiogenesis Advances Cystinosis Program With New Study and Phase 3 Plans for TTI-01028M ago
Company AnnouncementsThiogenesis Posts Positive Phase 2 MELAS Data, Backs Weight-Based Dosing for Lead Mitochondrial Drug9M ago
Company AnnouncementsThiogenesis to Present Late-Breaking Phase 2 MELAS Data on TTI-0102 at Mitocon 20269M agoCompany AnnouncementsThiogenesis to Showcase Mitochondrial Disease Clinical Progress at UMDF Webinar9M ago
Company AnnouncementsThiogenesis Therapeutics Announces Phase 3 Trial for Innovative Cystinosis Treatment11M ago
- Company AnnouncementsThiogenesis Reports Positive Interim Results and Pipeline Advancements11M ago
Company AnnouncementsThiogenesis Therapeutics Advances in MELAS Treatment with TTI-0102 Study12M agoTTI- Company AnnouncementsThiogenesis Therapeutics Advances LSS Treatment with New TTI-0102 Study12M agoTTI
Company AnnouncementsThiogenesis Extends Investor Relations Agreement with Capital Analytica1y ago
Company AnnouncementsThiogenesis Therapeutics Reports AGM Results and Corporate Milestones1y agoCompany AnnouncementsThiogenesis Therapeutics Corp Secures Over C$4.14 Million in Private Placement1y ago
Company AnnouncementsThiogenesis Therapeutics Announces $1.5 Million Private Placement to Fund Clinical Trials1y ago
Company AnnouncementsThiogenesis Advances Pediatric MASH Trial and Secures EU Patent1y ago
Company AnnouncementsThiogenesis to Showcase Promising Mitochondrial Treatments at UMDF Conference1y ago
Company AnnouncementsThiogenesis Expands Phase 2 MELAS Trial with New French Site1y ago
Company AnnouncementsThiogenesis Therapeutics Grants Stock Options to Directors1y ago